About GreenLight Biosciences
GreenLight Biosciences is a company based in Lexington (United States) founded in 2008 by Andrey Zarur.. GreenLight Biosciences has raised $225.05 million across 12 funding rounds from investors including ARE, United States Department of Agriculture and Khosla Ventures. The company has 287 employees as of December 31, 2022. GreenLight Biosciences offers products and services including Calantha and Norroa. GreenLight Biosciences operates in a competitive market with competitors including Veritas Genetics, Kailos, Yunhu Technology Group, ARCpoint Labs and Genesis Healthcare, among others.
- Headquarter Lexington, United States
- Employees 287 as on 31 Dec, 2022
- Founders Andrey Zarur
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Greenlight Biosciences, Inc.
-
Annual Revenue
$6.78 M325as on Dec 31, 2022
-
Net Profit
-
EBITDA
-
Total Equity Funding
$225.05 M (USD)
in 12 rounds
-
Latest Funding Round
$25 M (USD), Post-IPO
Apr 07, 2025
-
Investors
ARE
& 27 more
-
Employee Count
287
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GreenLight Biosciences
GreenLight Biosciences offers a comprehensive portfolio of products and services, including Calantha and Norroa. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Controls Colorado Potato Beetles in potato crops effectively and sustainably.
Protects honey bees from Varroa destructor mites through RNA-based solutions.
Unlock access to complete
Funding Insights of GreenLight Biosciences
GreenLight Biosciences has successfully raised a total of $225.05M across 12 strategic funding rounds. The most recent funding activity was a Post-IPO round of $25 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 12
- Last Round Post-IPO — $25.0M
-
First Round
First Round
(21 Dec 2009)
- Investors Count 28
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2025 | Amount | Post-IPO - GreenLight Biosciences | Valuation |
investors |
|
| Jul, 2024 | Amount | Grant - GreenLight Biosciences | Valuation |
investors |
|
| Mar, 2024 | Amount | Grant - GreenLight Biosciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in GreenLight Biosciences
GreenLight Biosciences has secured backing from 28 investors, including institutional and venture fund investors. Prominent investors backing the company include ARE, United States Department of Agriculture and Khosla Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Stage agnostic venture capital firm
|
Founded Year | Domain | Location | |
|
Investments are directed to food, agribusiness, and commodities sectors.
|
Founded Year | Domain | Location | |
|
VC firm that does early stage investments in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GreenLight Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - GreenLight Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Greenlight Biosciences Comparisons
Competitors of GreenLight Biosciences
GreenLight Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Veritas Genetics, Kailos, Yunhu Technology Group, ARCpoint Labs and Genesis Healthcare, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genetic testing products for health risks and traits are offered.
|
|
| domain | founded_year | HQ Location |
Provider of consumer-based genetic testing services
|
|
| domain | founded_year | HQ Location |
DNA testing services are provided via an online platform.
|
|
| domain | founded_year | HQ Location |
Provider of genetic testing services
|
|
| domain | founded_year | HQ Location |
Provider of consumer kits and genomic services for researchers
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Greenlight Biosciences
Frequently Asked Questions about GreenLight Biosciences
When was GreenLight Biosciences founded?
GreenLight Biosciences was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Where is GreenLight Biosciences located?
GreenLight Biosciences is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.
Who is the current CEO of GreenLight Biosciences?
Andrey Zarur is the current CEO of GreenLight Biosciences. They have also founded this company.
Is GreenLight Biosciences a funded company?
GreenLight Biosciences is a funded company, having raised a total of $225.05M across 12 funding rounds to date. The company's 1st funding round was a Grant of $325.13K, raised on Dec 21, 2009.
How many employees does GreenLight Biosciences have?
As of Dec 31, 2022, the latest employee count at GreenLight Biosciences is 287.
What is the annual revenue of GreenLight Biosciences?
Annual revenue of GreenLight Biosciences is $6.78M as on Dec 31, 2022.
What does GreenLight Biosciences do?
GreenLight Biosciences was founded in 2008 and is based in Lexington, United States. A platform for RNA-based products is provided for the life science industry. Applications include vaccine development, antibody therapies, pandemic preparation, crop management, plant protection, and support for bee and pollinator health. Operations focus on biotechnology solutions across agriculture and human health sectors.
Who are the top competitors of GreenLight Biosciences?
GreenLight Biosciences's top competitors include Veritas Genetics, ARCpoint Labs and Genesis Healthcare.
What products or services does GreenLight Biosciences offer?
GreenLight Biosciences offers Calantha and Norroa.
Who are GreenLight Biosciences's investors?
GreenLight Biosciences has 28 investors. Key investors include ARE, United States Department of Agriculture, Khosla Ventures, BNP Paribas Asset Management, and Greenlight Re.